Weihong Kuang

Dr. Weihong Kuang


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 March 2022 in Cell Death Discovery
Verified
Journal Article
Open access
PDF file
JLJie Liu
Jie Liu
ZRZhenxing Ren
Zhenxing Ren
LYLin Yang
Lin Yang
LZLulu Zhu
Lulu Zhu
YLYi Li
Yi Li
WKWeihong Kuang
Weihong Kuang
Ferroptosis is a type of cell death induced by the iron-dependent accumulation of lipid hydroperoxides and reactive oxygen species (ROS) in cells. Inhibiting ferroptosis is important for improving the survival of transplanted bone marrow-derived mesenchymal stem cells (BMSCs). Although it is known that NOP2/Sun RNA methyltransferase 5 (NSUN5) post-transcriptionally regulates ferroptosis in BMSCs through RNA methylation, the precise mechanisms underlying these effects have not been reported. In this study, we demonstrate that NSUN5 is downregulated in erastin-induced ferroptosis in BMSCs. Ferroptosis was inhibited by the overexpression ofNSUN5or ferritin heavy chain/light-chain (FTH1/FTL) and was enhanced byNSUN5knockdown. RNA immunoprecipitation experiments revealed that NSUN5 binds to FTH1/FTL, whileNSUN5depletion reduced the levels of 5-methylcytosine inFTH1/FTLRNA and increased intracellular iron concentrations, resulting in the downregulation of glutathione peroxidase 4 (GPX4) and the accumulation of ROS and lipid peroxidation products. Co-immunoprecipitation experiments demonstrated that the recognition ofFTH1andFTLby NSUN5 is dependent on the recruitment of tumor necrosis factor receptor-associated protein 1 (TRAP1). These results suggested that the NSUN5-FTH1/FTL pathway mediates ferroptosis in BMSCs and that the therapeutic targeting of components of this pathway may promote resistance to ferroptosis and improve the survival of transplanted BMSCs.

1 July 2020 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
HLHang Li
Hang Li
CZCaiping Zhao
Caiping Zhao
YTYe Tian
Ye Tian
JLJuan Lu
Juan Lu
GZGuiyu Zhang
Guiyu Zhang
MZmeiling Zhu
meiling Zhu
Src family kinases (SFKs) is a non-receptor protein tyrosine kinases family. They are crucial in signal transduction and regulation of various cell biological processes, such as proliferation, differentiation and apoptosis. The role and mechanism of SFKs in tumorigenesis have been widely studied. However, more and more studies have also shown that SFKs are involved in the pathogenesis of pulmonary fibrosis (PF). Myofibroblasts activation, epithelial-mesenchymal transition and inflammation response are three pivotal pathomechanisms in the development of pulmonary fibrotic disease. In this article, we summarize the roles of SFKs in these biological processes. SFKs play a crucial role in the pathogenesis of PF, making it a promising molecular target for the treatment of these diseases. We will pay special attention to the role of SFKs in idiopathic pulmonary fibrosis (IPF), and also emphasize the important findings in other pulmonary fibrotic diseases because their pathological mechanisms are similar. We will then describe the translation results obtained with SFKs inhibitors in basic and clinical studies.

8 November 2021 in Frontiers in Genetics
Verified
Journal Article
Open access
SZShuQiao Zhang
ShuQiao Zhang
XLXinYu Li
XinYu Li
CTChunzhi Tang
Chunzhi Tang
WKWeihong Kuang
Weihong Kuang
Background: Gastric carcinoma (GC) is a molecularly and phenotypically highly heterogeneous disease, making the prognostic prediction challenging. On the other hand, Inflammation as part of the active cross-talk between the tumor and the host in the tumor or its microenvironment could affect prognosis.Method: We established a prognostic multi lncRNAs signature that could better predict the prognosis of GC patients based on inflammation-related differentially expressed lncRNAs in GC.Results: We identified 10 differently expressed lncRNAs related to inflammation associated with GC prognosis. Kaplan-Meier survival analysis demonstrated that high-risk inflammation-related lncRNAs signature was related to poor prognosis of GC. Moreover, the inflammation-related lncRNAs signature had an AUC of 0.788, proving their utility in predicting GC prognosis. Indeed, our risk signature is more precise in predicting the prognosis of GC patients than traditional clinicopathological manifestations. Immune and tumor-related pathways for individuals in the low and high-risk groups were further revealed by GSEA. Moreover, TCGA based analysis revealed significant differences in HLA, MHC class-I, cytolytic activity, parainflammation, co-stimulation of APC, type II INF response, and type I INF response between the two risk groups. Immune checkpoints revealed CD86, TNFSF18, CD200, and LAIR1 were differently expressed between lowand high-risk groups.Conclusion: A novel inflammation-related lncRNAs (AC015660.1, LINC01094, AL512506.1, AC124067.2, AC016737.1, AL136115.1, AP000695.1, AC104695.3, LINC00449, AC090772.1) signature may provide insight into the new therapies and prognosis prediction for GC patients.

1 August 2021 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
WSWenwen Si
Wenwen Si
ZHZifeng Huang
Zifeng Huang
XLXinrong Li
Xinrong Li
LZLijun Zhao
Lijun Zhao
YJYichun Ji
Yichun Ji
MZmeiling Zhu
meiling Zhu

31 July 2019 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
JLJuan Lu
Juan Lu
XLXuelei Liu
Xuelei Liu
YTYe Tian
Ye Tian
HLHang Li
Hang Li
ZRZhenxing Ren
Zhenxing Ren
MZMeiling Zhu
Meiling Zhu
The objective of this study was to explore the neuroprotective effect of moxibustion on rats with Parkinson’s disease (PD) and its mechanism. A Parkinson’s disease model was established in rats using a two-point stereotactic 6-hydroxydopamine injection in the right substantia nigra (SN) and ventral tegmental area. The rats received moxibustion at the Baihui (GV20) and Sishencong (EX-HN1) acupoints for 20 minutes, six times a week, for 6 weeks. The right SN tissue was histologically and immunohistochemically examined. Differentially expressed genes (DEGs) were identified through RNA sequencing. In addition, the levels of tyrosine hydroxylase (TH), glutathione peroxidase 4 (GPX4), and ferritin heavy chain 1 (FTH1) in SN were measured. In comparison to the model group, the moxibustion group showed a significantly greater TH immunoreactivity and a higher behavioural score. In particular, moxibustion led to an increase in the number and morphological stability of SN neural cells. The functional pathway analysis showed that DEGs are closely related to the ferroptosis pathway. GPX4 and FTH1 in the SN were significantly overexpressed in the moxibustion-treated rats with PD. Moxibustion can effectively reduce the death of SN neurons, decrease the occurrence of ferroptosis, and increase the TH activity to protect the neurons in rats with PD. The protective mechanism may be associated with suppression of the ferroptosis.

1 May 2021 in Complementary Therapies in Clinical Practice
Verified
Journal Article
Closed access
JZJuan Zeng
Juan Zeng
YJYichun Ji
Yichun Ji
BLBingxue Liang
Bingxue Liang
GZGuiyu Zhang
Guiyu Zhang
DCDong-Feng Chen
Dong-Feng Chen
WKWeihong Kuang
Weihong Kuang